Journal of Chronic Fatigue Syndrome: Volume 3, Issue 1, 1997

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Titles and abstracts for the Journal of Chronic Fatigue Syndrome, Volume 3, Issue 1, 1997.

Volume 3, Issue 1, 1997[edit | edit source]

  • Literature in Review[1]
  • Pteridines and Neuroimmune Function and Pathology[2]
  • NeuroSPECT Findings in Children with Chronic Fatigue Syndrome[3]
  • A Screening Instrument for Chronic Fatigue Syndrome: Reliability and Validity[4]
  • A Preliminary Assessment of the Association of SCL-90-R Psychological Inventory Responses with Changes in Urinary Metabolites in Patients with Chronic Fatigue Syndrome[5]
  • Chronic Fatigue Syndrome: A Disorder of Central Cholinergic Transmission[6]
  • Introduction by Nancy G. Klimas & Roberto Patarca[7]

See also[edit | edit source]

References[edit | edit source]

  1. ↑ (1997). Literature in Review. Journal of Chronic Fatigue Syndrome, Vol. 3, Iss. 1, pp 87-91. http://dx.doi.org/10.1300/J092v03n01_07
  2. ↑ Roberto Patarca, Iris R. Bell, and Mary Ann Fletcher. (1997). Pteridines and Neuroimmune Function and Pathology.Journal of Chronic Fatigue Syndrome, Vol. 3, Iss. 1, pp 69-86. http://dx.doi.org/10.1300/J092v03n01_06
  3. ↑ Goldberg, Michael J.; Mena, Ismael; Darcourt, Jacques (1997), "NeuroSPECT Findings in Children with Chronic Fatigue Syndrome", Journal of Chronic Fatigue Syndrome, 3 (1): 61-67, doi:10.1300/J092v03n01_05
  4. ↑ Leonard A. Jason, Michael T. Ropacki, Nicole B. Santoro, Judith A. Richman, Wendy Heatherly, Renee Taylor, Joseph R. Ferrari, Trina M. Haneydavis, Alfred Rademaker, Josee Dupuis, Jacqueline Golding, Audrius V. Plioplys, and Sigita Plioplys. (1997). A Screening Instrument for Chronic Fatigue Syndrome: Reliability and Validity. Journal of Chronic Fatigue Syndrome, Vol. 3, Iss. 1, pp 39-59. http://dx.doi.org/10.1300/J092v03n01_04
  5. ↑ N.R. McGregor, R.H. Dunstan, H.L. Butt, T.K. Roberts, I.J. Klineberg, and M. Zerbes. (1997). A Preliminary Assessment of the Association of SCL-90-R Psychological Inventory Responses with Changes in Urinary Metabolites in Patients with Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome, Vol. 3, Iss. 1, pp 17-37. http://dx.doi.org/10.1300/J092v03n01_03
  6. ↑ A. Chaudhuri, T. Majeed, T. Dinan, and P. O. Behan. (1997). Chronic Fatigue Syndrome: A Disorder of Central Cholinergic Transmission. Journal of Chronic Fatigue Syndrome, Vol. 3, Iss. 1, pp 3-16. http://dx.doi.org/10.1300/J092v03n01_02
  7. ↑ Nancy G. Klimas & Roberto Patarca. (1997). Introduction. Journal of Chronic Fatigue Syndrome, Vol. 3, Iss. 1, pp 1-2. http://dx.doi.org/10.1300/J092v03n01_01

metabolite A chemical compound produced by, or involved in, metabolism. The term is often used to refer to the degradation products of drugs in the body.

cholinergic Involving the neurotransmitter acetylcholine. Cholinergic side effects include diarrhea, blurred vision, decreased intraocular pressure, contricted pupil in the eyes, sweating, increased saliva and mucus on the lungs, bronchial constriction, increased gastrointestinal tone, decreased blood pressure, slow heart rate, and contraction of bladder detrusor muscle. muscle spasms/cramps, low blood pressure, slowed heart rate, nausea and vomiting, increased saliva and sweating, shortness of breath, and urinating more often.

Retrieved from "https://me-pedia.org/w/index.php?title=Journal_of_Chronic_Fatigue_Syndrome:_Volume_3,_Issue_1,_1997&oldid=227245"